(Q27021322)

English

Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C- (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

0 references

0 references

dermatomyositis

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

inclusion body myositis

1 reference

based on heuristic

inferred from title

Frederick W. Miller

10

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Nicolino Ruperto

6

object named as

Nicolino Ruperto

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

David A. Isenberg

9

object named as

David Isenberg

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

author name string

Helene Alexanderson

4

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Anand Prahalad Rao

5

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Laura Herbelin

7

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Richard Barohn

8

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Lisa G Rider

1

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Victoria P Werth

2

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Adam M Huber

3

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

language of work or name

1 reference

publication date

1 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Arthritis Care and Research

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

63 Suppl 11

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

S11

0 references

S118-57

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Psychophysical bases of perceived exertion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

7 April 2017

Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Interrater reliability and aspects of validity of the myositis damage index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: A case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Inclusion body myositis: old and new concepts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Numerical scoring for the Classic BILAG index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Development and validation of the Dermatomyositis Skin Severity Index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Critical review of generic and dermatology-specific health-related quality of life instruments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

International research networks in pediatric rheumatology: the PRINTO perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

International consensus on preliminary definitions of improvement in adult and juvenile myositis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

10 years experience of the Dermatology Life Quality Index (DLQI).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Defining Clinical Improvement in Adult and Juvenile Myositis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 September 2017

Maximal isometric muscle strength: normative values and gender-specific relation to age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

31 May 2018

Validity of a vasculitis activity index for systemic necrotizing vasculitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

31 May 2018

Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

31 May 2018

A functional index in myositis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

31 May 2018

The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

31 May 2018

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

31 May 2018

Measurement of isometric force in children with and without Duchenne's muscular dystrophy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

31 May 2018

Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Intra-rater and inter-rater reliability of the 10-point Manual Muscle Test (MMT) of strength in children with juvenile idiopathic inflammatory myopathies (JIIM).

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

The physiological and physical determinants of functional ability measures in children with juvenile dermatomyositis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

What determines quality of life in inclusion body myositis?

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

A pilot randomized trial of oxandrolone in inclusion body myositis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Functional index-2: Validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Testing and reducing skindex-29 using Rasch analysis: Skindex-17.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Dermatology Life Quality Index: influence of an illustrated version.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

The Children's Dermatology Life Quality Index: validation of the cartoon version.

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Translating the science of quality of life into practice: What do dermatology life quality index scores mean?

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Reliability and validity of the myositis disease activity assessment tool

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Maximum voluntary isometric contraction: Reference values and clinical application

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. I. Physician, parent, and patient global assessments

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Preliminary validation and clinical meaning of the cutaneous assessment tool in juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1002%2FACR.20532

21 January 2018

Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 November 2018

Development of the myositis activities profile--validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 November 2018

Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 November 2018

Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 November 2018

The Juvenile Arthritis Quality of Life Questionnaire--development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 November 2018

Muscle strength assessment in polymyositis and dermatomyositis evaluation of the reliability and clinical use of a new, quantitative, easily applicable method.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 November 2018

Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 November 2018

The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3748930

28 November 2018

SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyos

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot trial of etanercept in the treatment of inclusion-body myositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional and isokinetic assessment of muscle strength in patients with idiopathic inflammatory myopathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospect

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Categorization of Skindex-29 Scores Using Mixture Analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of health status in children with juvenile rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative nailfold video capillaroscopy in patients with idiopathic inflammatory myopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dermatology quality of life scales--a measure of the impact of skin diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of body surface area involvement in atopic eczema: an impossible task?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective natural history study of inclusion body myositis: implications for clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Grip force in patients with rheumatoid arthritis and fibromyalgia and in healthy subjects. A study with the Grippit instrument

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22588740

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ACR.20532

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27021322&oldid=1525707189"